Your browser doesn't support javascript.
loading
Development of pathogenesis and therapeutics in myeloproliferative neoplasms / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma ; (12): 400-404, 2015.
Article in Chinese | WPRIM | ID: wpr-478481
ABSTRACT
This article introduces the genes related to pathogenesis and prognosis of myeloproliferative neoplasms (MPN) and the current situation of MPN domestic and overseas,which have been reported in the 56th ASH annual meeting.It is emphasized on essential evaluation of the risk score using IPSET in ET,Tefferi in PV and DIPSS-plus in PMF separately.It has assessed advancements in allogeneic hematopoietic stem cell transplantation,phlebotomy,cytoreductive therapy and drug therapy.The article pays more attention to aspirin,anagrelide,JAK2 targeted agent ruxolitinib and thalidomide which is domestically used in the treatment of PMF.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study / Prognostic study Language: Chinese Journal: Journal of Leukemia & Lymphoma Year: 2015 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study / Prognostic study Language: Chinese Journal: Journal of Leukemia & Lymphoma Year: 2015 Type: Article